These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cancers attributable to human papillomavirus infection. Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211 [Abstract] [Full Text] [Related]
7. Global burden of human papillomavirus and related diseases. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Vaccine; 2012 Nov 20; 30 Suppl 5():F12-23. PubMed ID: 23199955 [Abstract] [Full Text] [Related]
8. The HPV infection in males: an update. Giraldi G, De Luca d'Alessandro E. Ann Ig; 2012 Nov 20; 24(6):497-506. PubMed ID: 23234187 [Abstract] [Full Text] [Related]
9. Comprehensive control of human papillomavirus infections and related diseases. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012. Vaccine; 2013 Dec 29; 31 Suppl 5():F1-31. PubMed ID: 24331745 [Abstract] [Full Text] [Related]
10. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities. Louchini R, Goggin P, Steben M. Chronic Dis Can; 2008 Dec 29; 28(3):99-106. PubMed ID: 18341764 [Abstract] [Full Text] [Related]
11. Comprehensive control of human papillomavirus infections and related diseases. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012. Vaccine; 2013 Nov 22; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716 [Abstract] [Full Text] [Related]
14. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Cancer; 2008 Nov 15; 113(10 Suppl):2901-9. PubMed ID: 18980273 [Abstract] [Full Text] [Related]
15. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Cancer; 2008 Nov 15; 113(10 Suppl):2936-45. PubMed ID: 18980277 [Abstract] [Full Text] [Related]
16. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Jiménez W, Paszat L, Kupets R, Wilton A, Tinmouth J. Gynecol Oncol; 2009 Sep 15; 114(3):395-8. PubMed ID: 19501390 [Abstract] [Full Text] [Related]
17. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Gillison ML, Chaturvedi AK, Lowy DR. Cancer; 2008 Nov 15; 113(10 Suppl):3036-46. PubMed ID: 18980286 [Abstract] [Full Text] [Related]
18. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Prev Med; 2011 Oct 15; 53 Suppl 1():S12-21. PubMed ID: 21962466 [Abstract] [Full Text] [Related]